Beijing Konruns Pharmaceutical (603590.SS) Earnings Analysis
Beijing Konruns Pharmaceutical (603590.SS) has no confirmed upcoming earnings date. Trailing P/E 31.09.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 603590.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 603590.SS. This page updates as the calendar is published.
603590.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-22 | 0.3 CNY | n/a | n/a | n/a |
| 2025-09-29 | 0.2314 CNY | n/a | n/a | n/a |
| 2025-06-30 | 0.2929 CNY | n/a | n/a | n/a |
| 2025-04-25 | 0.28 CNY | n/a | n/a | n/a |
| 2024-12-31 | -0.44887 CNY | n/a | n/a | n/a |
603590.SS valuation and analyst view
| Trailing P/E | 31.09 |
|---|---|
| Trailing EPS | 1.072 CNY |
| Price / book | 1.61 |
| Dividend yield | 1.06% |
| Market cap | 5.22B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Beijing Konruns Pharmaceutical (603590.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 603590.SS. This page updates as the calendar is published.
Did 603590.SS beat earnings last quarter?
Consensus estimate data was not available for 603590.SS's 2026-04-22 report.
What is 603590.SS's current P/E ratio and EPS?
603590.SS trades at a trailing P/E of 31.09 on trailing EPS of 1.0718301939702963 CNY.
What do analysts rate 603590.SS?
603590.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.